Bladder cancer is the most common malignancy of the urinary tract and the ninth most
common malignancy in the world, with an estimated overall global 5-year prevalence of …

In the urinary tract, bladder cancer is the most common malignancy. It is a heterogenous
cancer type with approximately 30% presenting as muscle invasive bladder cancer with a …

Bladder cancer (BC) is the 10th most common cancer worldwide. Approximately one quarter
of patients with BC have muscle-invasive disease (MIBC). Muscle-invasive disease carries a …

Background Presence of lymph node metastases (LNM) is an important prognostic factor for
cancer-specific survival (CSS) in patients with upper tract urothelial carcinoma (UTUC). In …

Bladder cancer (BC) is the most common cancer in the urinary tract. It is a heterogeneous
cancer, with 70% of patients presenting with superficial tumors, which tend to recur but are …

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18 F]
fluoro-2-deoxy-d-glucose (18 F-FDG) has emerged as a powerful tool for the combined …

Objectives To evaluate the performance of dynamic contrast enhanced (DCE) magnetic
resonance (MR) imaging to assess the histological response after chemotherapy on bladder …

The purpose of this study covered the diagnostic accuracy and usefulness of positron
emission tomography/computed tomography (PET/CT) imaging in muscle invasive bladder …

PET/computed tomography (CT) has become one of the most important imaging modalities
for patients with cancer and PET/CT with F-18 fluorodeoxyglucose (FDG) has become …

Background The detection of lymph node metastases in bladder cancer has a major impact
on treatment decisions and patients prognosis. Due to limited value of conventional imaging …